Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
1,950,375
-
Share change
-
+434,151
-
Total reported value
-
$121,244,606
-
Put/Call ratio
-
6742%
-
Price per share
-
$62.16
-
Number of holders
-
48
-
Value change
-
+$26,978,491
-
Number of buys
-
16
-
Number of sells
-
15
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q3 2020
As of 30 Sep 2020,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,950,375 shares.
The largest 10 holders included
Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management), BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, Brinker Capital Investments, LLC, Orion Portfolio Solutions, LLC, CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MORGAN STANLEY, ROYAL BANK OF CANADA, and IMC-Chicago, LLC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.